自身免疫性溶血性贫血术语定义的系统综述
该系统综述检索2006年1月至2015年12月文献,评估自身免疫性溶血性贫血(AIHA)及其亚型、难治性疾病、疾病分期、严重程度、治疗反应标准和反应持久性定义的异质性。最终纳入84项研究,发现AIHA定义以溶血性贫血伴直接抗人球蛋白试验(DAT)阳性并排除其他病因为主(32/61,52%),但各术语定义存在显著异质性,提示需标准化AIHA术语。
要点
- AIHA最常定义为溶血性贫血伴DAT阳性并排除其他病因(32/61,52%),其中10项研究也认可DAT阴性AIHA。
- 贫血、溶血及排除标准定义差异大,原发性/继发性冷凝集素病/综合征定义不一致。
- 43项研究提供治疗反应标准,除来自1个中心的研究外几乎均独特;其他标准罕有定义。
核心结论
- AIHA术语定义存在显著异质性,需标准化AIHA术语。
研究设计与样本
- 系统综述,检索2006年1月至2015年12月Medline文献,辅以关键词检索,排除会议摘要、动物及非英语研究、病例数<10的研究。
- 检索获得1371篇文章,根据标题和摘要排除1209篇;两位作者分别独立审阅10%的摘要和16%的全文;全文审阅后纳入84项研究。
主要发现
- AIHA最常定义为溶血性贫血伴直接抗人球蛋白试验(DAT)阳性并排除其他病因(32/61,52%),但32项中10项也认可DAT阴性AIHA。
- 慢性淋巴细胞白血病文献中观察到DAT阴性AIHA诊断阈值较低。
- 贫血、溶血及排除标准定义差异大;原发性/继发性冷凝集素病/综合征定义不一致。
- 43项研究提供治疗反应标准,除来自1个中心的研究外几乎均独特;其他标准罕有定义。
- 仅7、0、3、2、2和3项研究分别提供温抗体型AIHA、阵发性冷性血红蛋白尿、混合型AIHA、AIHA严重程度、疾病分期和难治性AIHA的定义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The terminology applied to autoimmune hemolytic anemia (AIHA) seems inconsistent. We aimed to evaluate the consistency of definitions used for diagnosis and treatment. In this systematic review of literature from January 2006 to December 2015, we assessed heterogeneity in the definition of AIHA and its subtypes, refractory disease, disease phase, severity, criteria for treatment response, and response durability. A Medline search for anemia, hemolytic, autoimmune was supplemented with keyword searches. Main exclusions were conference abstracts, animal and non-English studies, and studies with <10 cases. Of 1371 articles retrieved, 1209 were excluded based on titles and abstracts. Two authors independently reviewed 10% and 16% of abstracts and full papers, respectively. After full-paper review, 84 studies were included. AIHA was most frequently (32 [52%] of 61) defined as hemolytic anemia with positive direct antiglobulin test (DAT) and exclusion of alternatives, but 10 of 32 also recognized DAT-negative AIHA. A lower threshold for diagnosis of DAT-negative AIHA was observed in literature on chronic lymphocytic leukemia. Definitions of anemia, hemolysis, and exclusion criteria showed substantial variation. Definitions of primary/secondary cold agglutinin disease/syndrome were not consistent. Forty-three studies provided criteria for treatment response, and other than studies from 1 center, these were almost entirely unique. Other criteria were rarely defined. Only 7, 0, 3, 2, 2, and 3 studies offered definitions of warm AIHA, paroxysmal cold hemoglobinuria, mixed AIHA, AIHA severity, disease phase, and refractory AIHA, respectively. Marked heterogeneity in the time period sampled indicates the need to standardize AIHA terminology.
引用
- Hill QA, Hill A, Berentsen S, et al. Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment. Blood Adv. 2019. PMID: 31235526. doi:10.1182/bloodadvances.2019000036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。